Zachary Klaassen discusses the NureCombo Trial with Chiara Mercinelli, examining neoadjuvant therapy for muscle-invasive bladder cancer. This phase II trial investigated nab-paclitaxel plus nivolumab ...

NCI study showing 85% of PSMA-positive BCR patients avoid treatment with surveillance approach, PSMA PET in Biochemical Recurrence: When to Treat vs When to Wait with Ravi Madan, tian zhang.

June 23, 2025 Darolutamide + docetaxel + androgen-deprivation therapy (ADT) significantly improved overall survival (OS) and delayed time to disease progression versus docetaxel + ADT in ARASENS ...

In [18F]F-PSMA-1007 PET imaging, focal bone uptake without morphological correlate (MC) on CT, is often classified as benign. In [68Ga]Ga-PSMA-11, intense focal uptake without MC in a classical ...

Trimodality therapy (TMT), consisting of maximal transurethral resection of bladder tumor (TURBT) followed by concurrent chemoradiotherapy, has emerged as a bladder-sparing alternative to radical ...

Previous research on Radium-223 treatment patterns in metastatic prostate cancer has been limited to select sites, oncology practices, or claims databases. Limited data exists on the use and outcomes ...

Leslie Ballas speaks with Timothy Showalter about a multimodal artificial intelligence-based prostate cancer test. Dr. Showalter explains how ArteraAI analyzes H&E-stained biopsy slides using computer ...

PDIGREE phase III adaptive, enrolled 1000+ metastatic kidney cancer patients across 500+ sites, ASCO 2025 results and innovative treatment strategies, PDIGREE Trial Tests Adaptive Immunotherapy ...

Enfortumab vedotin (EV) in combination with pembrolizumab (P) has led to a new paradigm for the treatment of metastatic urothelial carcinoma (mUC). Since the presentation of the results of the EV-302 ...

(UroToday.com) Dr. Michael Abern presented the highly anticipated primary results from the Expand URO study, a prospective, multi-center clinical trial evaluating the effectiveness, safety, and ...

VIOLET trial investigating Terbium-161 PSMA therapy for advanced prostate cancer, radiopharmaceutical combining beta and Auger emissions, dosimetry findings, treatment protocol, advantages for ...

Ashish Kamat moderates a discussion with Paolo Gontero and Maria Carmen Mir addressing management approaches for BCG-unresponsive bladder cancer. Dr. Gontero highlights the limited treatment options ...